A detailed history of Titleist Asset Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Titleist Asset Management, LLC holds 4,954 shares of HALO stock, worth $226,150. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,954
Previous 4,994 0.8%
Holding current value
$226,150
Previous $261 Million 8.44%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$51.3 - $64.42 $2,052 - $2,576
-40 Reduced 0.8%
4,954 $284 Million
Q2 2024

Aug 12, 2024

SELL
$37.81 - $52.4 $756 - $1,048
-20 Reduced 0.4%
4,994 $261 Million
Q1 2024

May 15, 2024

BUY
$33.68 - $41.95 $168,871 - $210,337
5,014 New
5,014 $204 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.36B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Titleist Asset Management, LLC Portfolio

Follow Titleist Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, LLC with notifications on news.